Provided By PR Newswire
Last update: Dec 8, 2021
WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
Read more at prnewswire.com586.49
+10.14 (+1.76%)
Find more stocks in the Stock Screener


